Elanco Animal Health (ELAN) Cash from Investing Activities Growth (1y) (2018 - 2026)
Powered by 
Analysis
Elanco Animal Health (ELAN) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn | 24.18% |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn | -41.51% |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | -96.43% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | -133.88% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -96.43% |
| Mar 31, 2026 | -3.45% |
| Dec 31, 2025 | 28.89% |
| Sep 30, 2025 | -108.12% |
| Jun 30, 2025 | -69.70% |
| Mar 31, 2025 | -256.76% |
| Dec 31, 2024 | -157.14% |
| Sep 30, 2024 | 3,555.56% |
| Jun 30, 2024 | 23.26% |
| Mar 31, 2024 | 167.27% |
| Dec 31, 2023 | 53.95% |
| Sep 30, 2023 | 2.70% |
| Jun 30, 2023 | -16.22% |
| Mar 31, 2023 | -89.66% |
| Dec 31, 2022 | -2.70% |
| Sep 30, 2022 | 91.61% |
| Jun 30, 2022 | -48.00% |
| Mar 31, 2022 | -390.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 90.61% |